by adminAdrianRamirez | Nov 13, 2018 | HempMeds Brasil, HempMeds Mexico, Press Releases
SAN DIEGO, Nov. 13, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that subsidiary HempMeds® Brasil will be a premier sponsor at the CannX Brazil Conference in São Paulo on Nov....
by adminAdrianRamirez | Nov 13, 2018 | HempMeds Brasil, Kannaway, Media Coverage
Marijuana legalization, medical cannabis in Brazil, and CBD for Pets lead Medical Marijuana, Inc.’s headlines in the media this week. As a leader in the cannabis industry, Medical Marijuana, Inc. works hard to expand access to legal, safe cannabinoids around the...
by adminAdrianRamirez | Nov 8, 2018 | HempMeds, Press Releases
SAN DIEGO, Nov. 8, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that subsidiary HempMeds® will exhibit its line of award-winning cannabidiol (CBD) hemp oil products at...
by adminAdrianRamirez | Nov 7, 2018 | Press Releases
SAN DIEGO, Nov. 6, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that Medical Marijuana, Inc. CEO Dr. Stuart Titus has been invited to speak at the CBD Symposium on November 6,...
by adminAdrianRamirez | Nov 7, 2018 | HempMeds, Press Releases
SAN DIEGO, Nov. 7, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® will be exhibiting its line of cannabidiol (CBD) hemp oil products at SupplySide West,...